<!DOCTYPE html>
<html>
  <head>
    <title>ImmunoSense</title>
    <meta charset="utf-8">
    <meta name="author" content="Alistair Bailey" />
    <link href="libs/remark-css/default.css" rel="stylesheet" />
    <link href="libs/remark-css/ninjutsu.css" rel="stylesheet" />
    <script src="libs/htmlwidgets/htmlwidgets.js"></script>
    <script src="libs/jquery/jquery.min.js"></script>
    <link href="libs/datatables-css/datatables-crosstalk.css" rel="stylesheet" />
    <script src="libs/datatables-binding/datatables.js"></script>
    <link href="libs/dt-core/css/jquery.dataTables.min.css" rel="stylesheet" />
    <link href="libs/dt-core/css/jquery.dataTables.extra.css" rel="stylesheet" />
    <script src="libs/dt-core/js/jquery.dataTables.min.js"></script>
    <link href="libs/crosstalk/css/crosstalk.css" rel="stylesheet" />
    <script src="libs/crosstalk/js/crosstalk.min.js"></script>
    <link rel="stylesheet" href="uos-fonts.css" type="text/css" />
    <link rel="stylesheet" href="uos.css" type="text/css" />
    <link rel="stylesheet" href="assets\ninpo.css" type="text/css" />
  </head>
  <body>
    <textarea id="source">
class: center, middle, inverse, title-slide

# ImmunoSense
### Alistair Bailey
### 6th March 2019

---




class: center,middle

<!--gt table start-->
<table style="font-family:-apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;display:table;border-collapse:collapse;margin-left:auto;margin-right:auto;color:#000000;font-size:16px;background-color:#FFFFFF;width:auto;border-top-style:solid;border-top-width:2px;border-top-color:#A8A8A8;">
<thead>
<tr>
<th colspan='6' style="background-color:#FFFFFF;border-bottom-color:#FFFFFF;color:#000000;font-size:125%;padding-top:4px;padding-bottom:1px;border-bottom-width:0;text-align:center;font-weight:normal;" >Summary of ImmunoSense Objectives</th>
</tr>
<tr>
<th colspan='6' style="background-color:#FFFFFF;border-bottom-color:#FFFFFF;color:#000000;font-size:85%;padding-top:1px;padding-bottom:4px;border-top-color:#FFFFFF;border-top-width:0;border-bottom-style:solid;border-bottom-width:2px;border-bottom-color:#A8A8A8;text-align:center;font-weight:normal;" >6th March 2019</th>
</tr>
</thead>
<tr>
<th style="color:#000000;background-color:#FFFFFF;font-size:16px;font-weight:initial;vertical-align:middle;padding:10px;margin:10px;text-align:left;" rowspan='1' colspan='1'>Experiments</th>
<th style="color:#000000;background-color:#FFFFFF;font-size:16px;font-weight:initial;vertical-align:middle;padding:10px;margin:10px;text-align:left;" rowspan='1' colspan='1'>Treatments</th>
<th style="color:#000000;background-color:#FFFFFF;font-size:16px;font-weight:initial;vertical-align:middle;padding:10px;margin:10px;text-align:left;" rowspan='1' colspan='1'>Cell culture</th>
<th style="color:#000000;background-color:#FFFFFF;font-size:16px;font-weight:initial;vertical-align:middle;padding:10px;margin:10px;text-align:left;" rowspan='1' colspan='1'>Sample preparation</th>
<th style="color:#000000;background-color:#FFFFFF;font-size:16px;font-weight:initial;vertical-align:middle;padding:10px;margin:10px;text-align:left;" rowspan='1' colspan='1'>Mass spectrometry</th>
<th style="color:#000000;background-color:#FFFFFF;font-size:16px;font-weight:initial;vertical-align:middle;padding:10px;margin:10px;text-align:left;" rowspan='1' colspan='1'>Data Analysis</th>
</tr>
<tbody style="border-top-style:solid;border-top-width:2px;border-top-color:#A8A8A8;border-bottom-style:solid;border-bottom-width:2px;border-bottom-color:#A8A8A8;">
<tr>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;">HLA typing</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
</tr>
<tr>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;">Transfectant generation<sup style="font-style:italic;font-size:65%;">1</sup></td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
</tr>
<tr>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;">Cell viability assays</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;">DNCB,DPCP</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
</tr>
<tr>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;">Cytotoxicity assays</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;">DNCB,DPCP</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
</tr>
<tr>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;">MHC I and II surface expression</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;">DNCB,DPCP</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
</tr>
<tr>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;">HaCaT peptidomes<sup style="font-style:italic;font-size:65%;">2</sup></td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;">DNCB,DPCP</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:red;font-weight:bold;">To-do</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:red;font-weight:bold;">To-do</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:red;font-weight:bold;">To-do</td>
</tr>
<tr>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;">HaCaT A2 peptidomes<sup style="font-style:italic;font-size:65%;">2</sup></td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;">DNCB,DPCP</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:red;font-weight:bold;">To-do</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:red;font-weight:bold;">To-do</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:red;font-weight:bold;">To-do</td>
</tr>
<tr>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;">Protein turnover assays</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;">DNCB,DPCP</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:blue;font-weight:bold;">Completed</td>
<td style="background-color:#f2f2f2;padding:10px;margin:10px;vertical-align:middle;text-align:left;color:orange;font-weight:bold;">In process</td>
</tr>
<tr>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;">Peptide synthesis and modification<sup style="font-style:italic;font-size:65%;">3</sup></td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;">DNCB</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:grey;">NA</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:orange;font-weight:bold;">In process</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:red;font-weight:bold;">To-do</td>
<td style="padding:10px;margin:10px;vertical-align:middle;text-align:left;color:red;font-weight:bold;">To-do</td>
</tr>
</tbody>
<tfoot>
<tr>
<td colspan='6' style="font-size:90%;padding:4px;"><sup style="font-style:italic;font-size:65%;"><em>1</em></sup> HaCaT HLA-A2 transfectant generated by Rachel Darley<br /><sup style="font-style:italic;font-size:65%;"><em>2</em></sup> These peptidomes are three new replicates
        performed using Ben Nicholas's improved purification method, and with treatment
        dose at 5 &mu;M treatment. Approx. 4 weeks work to complete.<br /><sup style="font-style:italic;font-size:65%;"><em>3</em></sup> Four peptides identified from 
                                     original peptidome analysis for clinical assays.
                                     Approx. 2 weeks work to complete.</td>
</tr>
</tfoot></table>
<!--gt table end-->

---

class: split-two 

.column.inverse[.content.center.vmiddle[

# Hypothesis

.horizon-1.bold[DNCB] (2,4-Dinitrochlorobenzene) and .horizon-1.bold[DPCP] (Diphenylcyclopropenone)
modified peptides stimulate CD8&lt;sup&gt;+&lt;/sup&gt; T-cells

]]

.column.horizon-1-slide[.content.middle.center[

&lt;img src="img/mhc-dncb-peptide.png" width="85%" /&gt;
]]

---

class: split-two 

.column.inverse[.content.center.vmiddle[

# Hypothesis

.horizon-1.bold[DNCB] (2,4-Dinitrochlorobenzene) and .horizon-1.bold[DPCP] (Diphenylcyclopropenone)
modulate the peptidome

]]

.column.horizon-1-slide[.content.vmiddle.center[
![](img/newtons-cradle.gif)

]]

---

layout: false
class: split-33 
.column.inverse[.content.center.vmiddle[

## HaCaTs express MHC class I, but not MHC class II

]]

.column.horizon-1-slide[.content.center.vmiddle[

&lt;img src="unilever-01-03-2019_files/figure-html/facs-data-1.png" width="90%" /&gt;


]]

.remark-slide-number {display: none;}

---

layout: false
class: split-33 

.column.inverse[.content.center.vmiddle[

# At what concentration are DNCB and DPCP toxic?

]]

.column.horizon-1-slide[.content.center.vmiddle[

&lt;img src="unilever-01-03-2019_files/figure-html/cell-viability-1.png" width="90%" /&gt;

]]

---


class: inverse
background-image: url(img/hacat-a2-04-01-2019.jpg)
background-size: 100%

# .content.black.bold[Wildtype HaCaT cells]

---

layout: false
class: split-two 

.column.inverse[.content.center.vmiddle[

Number of peptide N-mers, n = 6

&lt;img src="unilever-01-03-2019_files/figure-html/wt-histograms-1-1.png" width="504" /&gt;

]]

.column.inverse[.content.center.vmiddle[

Percentage of peptide N-mers, n = 6

&lt;img src="unilever-01-03-2019_files/figure-html/wt-histograms-2-1.png" width="504" /&gt;

]]

---

class: split-two 

.column.inverse[.content.center.vmiddle[

Intersection between all peptides

&lt;img src="unilever-01-03-2019_files/figure-html/upset-plot-1.png" width="100%" /&gt;

]]

.column.horizon-1-slide[.content.center.vmiddle[

Intersection of 9-mers

&lt;img src="unilever-01-03-2019_files/figure-html/upset-2,upset-plot-1.png" width="100%" /&gt;

]]

---

class: split-two

.column.inverse[.content.center.vmiddle[

Immune epitope database peptides

&lt;img src="unilever-01-03-2019_files/figure-html/iedb-logos-1.png" width="100%" /&gt;

]]

.column.horizon-1-slide[.content.center.vmiddle[

Peptide classification model

&lt;img src="unilever-01-03-2019_files/figure-html/wt_logos-1.png" width="100%" /&gt;

]]

???

There were 1000 9-mer peptides for each allotype for the IEDB peptides

---
class: inverse

&lt;img src="unilever-01-03-2019_files/figure-html/wt_preds-1.png" width="100%" /&gt;

---

class: split-two

.column.inverse[.content.center.vmiddle[

## DNCB modified peptides

HLA-B*40:01, 9mer, .horizon-1.bold[AETEC(+DNP)RYAL], &lt;br&gt; Keratin type I cytoskeletal 13

HLA-A*31:01, 10mer, .horizon-1.bold[RFC(+DNP)PFAERTR], Glutathione S-transferase omega-1 

]]

.column.horizon-1-slide[.content.center.vmiddle[

<div id="htmlwidget-eac7fff8f263a3b7e102" style="width:100%;height:auto;" class="datatables html-widget"></div>
<script type="application/json" data-for="htmlwidget-eac7fff8f263a3b7e102">{"x":{"filter":"none","data":[["AETEC(+166.00)RYAL","AETEC(+166.00)RYAL","AETEC(+166.00)RYAL","AETEC(+166.00)RYAL","RFC(+166.00)PFAERTR","RFC(+166.00)PFAERTR","RFC(+166.00)PFAERTR"],["DNCB 1A","DNCB 1B","DNCB 3A","DNCB 3B","DNCB 1A","DNCB 1B","DNCB 3A"]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th>Peptide<\/th>\n      <th>Replicate<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"dom":"t","order":[],"autoWidth":false,"orderClasses":false}},"evals":[],"jsHooks":[]}</script>

]]
---

class: split-two

.column.inverse[.content.center.vmiddle[

HLA-B*40:01, 9mer, .horizon-1.bold[AETEC(+DNP)RYAL] &lt;br&gt; Keratin type I cytoskeletal 13


&lt;img src="unilever-01-03-2019_files/figure-html/kera-scan-1.png" width="100%" /&gt;

.tiny[Doubly charged peptide: DNCB-D&lt;sub&gt;3&lt;/sub&gt; is 3 mass units heavier, divided by 2 charges = 1.5 Da mass difference]

]]

.column.horizon-1-slide[.content.center.vmiddle[

HLA-A*31:01, 10mer, .white.bold[RFC(+DNP)PFAERTR] &lt;br&gt; Glutathione S-transferase omega-1

&lt;img src="unilever-01-03-2019_files/figure-html/glut-scan-1.png" width="100%" /&gt;

.tiny[Triply charged peptide: DNCB-D&lt;sub&gt;3&lt;/sub&gt; is 3 mass units heavier, divided by 3 charges = 1 Da mass difference]

]]

---

class: split-three

.column.inverse[.content.center.vmiddle[

HLA-B\*40:01 9-mer, AETEC(+DNP)RYAL &lt;br&gt; .small[Keratin, type I cytoskeletal 13]

&lt;img src="img/b40_keratin_dnp_top_2.png" width="1524" /&gt;

]]

.column.horizon-1-slide[.content.center.vmiddle[

HLA-A\*31:01, 10-mer RFC(+DNP)PFAERTR &lt;br&gt; .small[Glutathione S-transferase omega-1] 

&lt;img src="img/a31_glut_dnp_top.png" width="1621" /&gt;

]]

.column.horizon-2-slide[.content.center.vmiddle[

.small[Glutathione S-transferase omega-1]

&lt;img src="img/glut_transferase.png" width="1227" /&gt;

]]

---

class: inverse
background-image: url(img/hacat-a2-04-01-2019.jpg)
background-size: 100%

# .content.black.bold[HaCaT HLA-A*02:01 &lt;br&gt; transfectant cells]

---

class: split-two 

.column.inverse[.content.center.vmiddle[

Number of peptide N-mers, n = 3

&lt;img src="unilever-01-03-2019_files/figure-html/unnamed-chunk-2-1.png" width="504" /&gt;

]]

.column.inverse[.content.center.vmiddle[

Percentage of peptide N-mers, n = 3

&lt;img src="unilever-01-03-2019_files/figure-html/unnamed-chunk-3-1.png" width="504" /&gt;

]]
---

class: split-two 

.column.inverse[.content.center.vmiddle[

Intersection between all peptides

&lt;img src="unilever-01-03-2019_files/figure-html/upset-a2-1.png" width="100%" /&gt;

]]

.column.horizon-1-slide[.content.center.vmiddle[

Intersection of 9-mers

&lt;img src="unilever-01-03-2019_files/figure-html/upset-2-a2-1.png" width="100%" /&gt;

]]

---

class: split-two

.column.inverse[.content.center.vmiddle[

Immune epitope database peptides

&lt;img src="unilever-01-03-2019_files/figure-html/iedb-a2-logos-1.png" width="100%" /&gt;

]]

.column.horizon-1-slide[.content.center.vmiddle[

Peptide classification model

&lt;img src="unilever-01-03-2019_files/figure-html/a2_logos-1.png" width="100%" /&gt;

]]

???

There were 1000 9-mer peptides for each allotype for the IEDB peptides

---
class: inverse

&lt;img src="unilever-01-03-2019_files/figure-html/a2_preds-1.png" width="100%" /&gt;

---

class: split-two

.column.inverse[.content.center.vmiddle[

## DNCB modified peptides

HLA-A\*02:01 9-mer, .horizon-1.bold[GLLDPQC(+DNP)RL] &lt;br&gt; Ribonuclease inhibitor

HLA-A\*02:01 10-mer, .horizon-1.bold[KLLEGEEC(+DNP)RL] &lt;br&gt; Keratin, type II cytoskeletal 5

]]

.column.horizon-1-slide[.content.center.vmiddle[

<div id="htmlwidget-26578973f36d5e2d7a08" style="width:100%;height:auto;" class="datatables html-widget"></div>
<script type="application/json" data-for="htmlwidget-26578973f36d5e2d7a08">{"x":{"filter":"none","data":[["GLLDPQC(+166.00)RL","KLLEGEEC(+166.00)RL","KLLEGEEC(+166.00)RL"],["DNCB 2","DNCB 2","DNCB 3"]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th>Peptide<\/th>\n      <th>Replicate<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"dom":"t","order":[],"autoWidth":false,"orderClasses":false}},"evals":[],"jsHooks":[]}</script>

]]
---

class: split-two

.column.inverse[.content.center.vmiddle[

HLA-A*02:01, 9-mer, .bold.horizon-1[GLLDPQC(+DNP)RL] &lt;br&gt; Ribonuclease inhibitor

&lt;img src="unilever-01-03-2019_files/figure-html/a2-rini-scan-1.png" width="100%" /&gt;

.tiny[Doubly charged peptide: DNCB-D&lt;sub&gt;3&lt;/sub&gt; is 3 mass units heavier, divided by 2 charges = 1.5 Da mass difference]

]]

.column.horizon-1-slide[.content.center.vmiddle[

HLA-A*02:01, 10-mer, .bold.white[KLLEGEEC(+DNP)RL] &lt;br&gt; Keratin type II cytoskeletal 5

&lt;img src="unilever-01-03-2019_files/figure-html/a2-ker-scan-1.png" width="100%" /&gt;

.tiny[Triply charged peptide: DNCB-D&lt;sub&gt;3&lt;/sub&gt; is 3 mass units heavier, divided by 3 charges = 1 Da mass difference]

]]

---

class: split-two

.column.inverse[.content.center.vmiddle[

HLA-A\*02:01, 9-mer, GLLDPQC(+DNP)RL &lt;br&gt; .small[Ribonuclease inhibitor]

&lt;img src="img/rini_dnp_modified_peptide.png" width="1621" /&gt;


]]

.column.horizon-1-slide[.content.center.vmiddle[

HLA-A\*02:01, 10-mer, KLLEGEEC(+DNP)RL &lt;br&gt; .small[Keratin, type II cytoskeletal 5] 

&lt;img src="img/keratin_dnp_modified_peptide.png" width="1621" /&gt;

]]

---

class: inverse, middle, center

# Protein turnover

---

class: inverse

&lt;img src="unilever-01-03-2019_files/figure-html/example-turnover-1.png" width="100%" /&gt;


---

layout: true
class: inverse with-border border-white

.column[
  .split-five[
  .row.bg-main1[.content[
# Recap 
  ]]
  .row.bg-main2[.content[
.horizon-1[No support for altered peptidome hypothesis yet:] &lt;br&gt;
The majority of the peptidome is observed `\(\pm\)` sensitiser.
  ]]
  .row.bg-main3[.content[
.horizon-1[Support for the direct stimulation hypothesis:] &lt;br&gt;
Observation of sensitiser modified peptides.
  ]]
  .row.bg-main4[.content[
.horizon-1[Evidence for sensitiser effect on cellular detoxification mechanism:] &lt;br&gt;
Modification of Glutathione S-transferase omega-1.
  ]]
  .row.bg-main5[.content[
.horizon-1[Assessment of treatment toxicity HaCaTs:] &lt;br&gt; 
Peptidome repeats with DNCB and DPCP treatment at 5 `\(\mu\)`M
  ]]
]]

---

class: gray-row2-col1 gray-row3-col1 gray-row4-col1 gray-row5-col1
count: false

---

class: gray-row3-col1 gray-row4-col1 gray-row5-col1
count: false

---

class: gray-row4-col1 gray-row5-col1
count: false
---

class: gray-row5-col1
count: false

---

count: false
---
    </textarea>
<script src="libs/remark-latest.min.js"></script>
<script>var slideshow = remark.create({
"highlightStyle": "github",
"highlightLines": true,
"countIncrementalSlides": false,
"ratio": "16:9"
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function() {
  var d = document, s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})();</script>

<script>
(function() {
  var i, text, code, codes = document.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
})();
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
